Literature DB >> 1712153

Septic shock.

A R Dal Nogare1.   

Abstract

Septic shock (SS) is the most common type of shock encountered by internists, and its prevalence appears to be increasing. SS complicates all types of infections. The hemodynamic characteristics of SS include a low systemic vascular resistance and an elevated, but relatively inadequate, cardiac output. A cardiomyopathy frequently occurs. The major endogenous mediator of SS is tumor necrosis factor, and interleukins-1 and -2 may also contribute. Important secondary phenomena include release of platelet activating factor, vasodilator prostaglandins, and upregulation of adhesion molecules on polymorphonuclear leukocytes and endothelial cells. Current therapy is often ineffectual, and potentially promising new therapeutic approaches are reviewed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712153

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  14 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  Systemic pressure-flow reactivity to norepinephrine in rabbits: impact of endotoxin and fluid loading.

Authors:  A Ricard-Hibon; M R Losser; R Kong; S Beloucif; B Teisseire; D Payen
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

3.  Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat.

Authors:  M T Heneka; P A Löschmann; H Osswald
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Parathyroid hormone-related protein is induced during lethal endotoxemia and contributes to endotoxin-induced mortality in rodents.

Authors:  J L Funk; A H Moser; G J Strewler; K R Feingold; C Grünfeld
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

5.  Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model.

Authors:  J E Wang; P F Jørgensen; M Almlöf; C Thiemermann; S J Foster; A O Aasen; R Solberg
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 6.  Clinical experience with platelet-activating factor antagonists. Past, present, and near future.

Authors:  P Guinot
Journal:  Clin Rev Allergy       Date:  1994

7.  Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.

Authors:  J Sörensen; B Kald; C Tagesson; M Lindahl
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

Review 8.  Septic shock: pathogenesis and treatment.

Authors:  L Castillo; M Sanchez
Journal:  Indian J Pediatr       Date:  1993 May-Jun       Impact factor: 1.967

9.  A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.

Authors:  J Schilling; M Cakmakci; U Bättig; S Geroulanos
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

10.  Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia.

Authors:  Tetsuaki Hashiguchi; Yasuyuki Kakihana; Sumikazu Isowaki; Tamotsu Kuniyoshi; Tatsuya Kaminosono; Etsuro Nagata; Kazumi Tobo; Masamichi Tahara; Naoko Okayama; Yuki Arakawa; Yoshie Kakihara; Tsuyoshi Goromaru; Nobuo Nakanishi; Hiroe Nakazawa; Yuichi Kanmura
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.